Vertex Pharmaceuticals Incorporated
523.93USD
-11.2400 (-2.10%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on VRTX.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.08▼ | $4.91 | 2 | 0 |
| Next quarter | $4.62▼ | $5.01 | 2 | 0 |
| Current year | $17.88▼ | $19.04 | 2 | 0 |
| Next year | $20.42▼ | $21.5 | 3 | 0 |
Beat in 2 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $4.75 | $4.73 | -0.02 (-0.3%) |
| 2026-03-31 | $4.31 | $4.47 | +0.16 (+3.8%) |
| 2025-12-31 | $5.15 | $5.03 | -0.12 (-2.3%) |
| 2025-09-30 | $4.58 | $4.8 | +0.22 (+4.9%) |
554 ratings from 47 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| RBC Capital | Maintained | Outperform | $570 $576 | Oct 8, 2026 |
| UBS | Maintained | Buy | $585 $615 | Sep 28, 2026 |
| Truist Securities | Maintained | Buy | $560 $565 | Aug 5, 2026 |
| Barclays | Maintained | Overweight | $615 $617 | Aug 5, 2026 |
| TD Cowen | Maintained | Buy | $525 $550 | Aug 4, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $590 $595 | Aug 4, 2026 |
| Canaccord Genuity | Maintained | Hold | $436 $442 | Aug 4, 2026 |
| UBS | Maintained | Buy | $545 $585 | Jul 13, 2026 |
| Truist Securities | Maintained | Buy | $542 $560 | Jul 13, 2026 |
| RBC Capital | Maintained | Outperform | $543 $570 | Jul 7, 2026 |
| Baird | Maintained | Underperform | $330 $350 | Jul 7, 2026 |
| Barclays | Maintained | Overweight | $607 $615 | May 6, 2026 |
| Canaccord Genuity | Maintained | Hold | $437 $436 | May 5, 2026 |
| Morgan Stanley | Maintained | Overweight | $612 $616 | May 5, 2026 |
| Bernstein | Maintained | Outperform | $577 $572 | May 5, 2026 |
| RBC Capital | Maintained | Outperform | $541 $543 | May 5, 2026 |
| Canaccord Genuity | Maintained | Hold | $441 $437 | Apr 30, 2026 |
| Morgan Stanley | Maintained | Overweight | $596 $612 | Apr 10, 2026 |
| Maxim Group | Upgraded from Hold | Buy | $575 | Mar 18, 2026 |
| Truist Securities | Maintained | Buy | $490 $525 | Mar 11, 2026 |
| Morgan Stanley | Maintained | Overweight | $570 $596 | Mar 10, 2026 |
| B of A Securities | Maintained | Buy | $571 $598 | Mar 10, 2026 |
| Citigroup | Maintained | Buy | $575 $585 | Mar 10, 2026 |
| Oppenheimer | Maintained | Outperform | $540 $600 | Mar 10, 2026 |
| Jefferies | Initiated | Buy | $580 | Mar 10, 2026 |
154 filings from 26 insiders · 11 buy / 14 sell over 6m
Officers and directors of VRTX, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Brennan Daniel J.Director | Grant | 795 | $503.47 | $400k | Oct 20, 2026 |
| SACHS BRUCE IDirector | GrantDeferred Stock Units | 92.694 | $512.44 | $48k | Oct 15, 2026 |
| Garber Alan MDirector | GrantDeferred Stock Units | 29.272 | $512.44 | $15k | Oct 15, 2026 |
| van Grunsven JasperOfficer, EVP, CP and NPPO | Grant | 8.7k | — | — | Sep 8, 2026 |
| Ambrose KristenOfficer, SVP & Chief Accounting Officer | Grant | 5.0k | — | — | Aug 28, 2026 |
| SACHS BRUCE IDirector | Gift | 6.0k | — | — | Aug 27, 2026 |
| TATSIS OURANIAOfficer | Grant | 8.3k | — | — | Jul 21, 2026 |
| SACHDEV AMITOfficer | Grant | 8.3k | — | — | Jul 21, 2026 |
| MCKECHNIE DUNCAN J.Officer | Sell | 1.5k | $519.00 | $800k | Jul 2, 2026 |
| TATSIS OURANIAOfficer | Sell | 1.5k | $524.99 | $787k | Jul 2, 2026 |
| LIU JOYOfficer | Sell | 828 | $502.71 | $416k | Jul 1, 2026 |
| BOZIC CARMENOfficer | Sell | 596 | $482.50 | $288k | Jun 26, 2026 |
| BOZIC CARMENOfficer | Sell | 1.0k | $462.17 | $471k | Jun 18, 2026 |
| BOZIC CARMENOfficer | Sell | 4.1k | $450.00 | $1.83M | Jun 15, 2026 |
| BOZIC CARMENOfficer | Sell | 1.7k | $450.00 | $785k | Jun 5, 2026 |
| LIU JOYOfficer | Sell | 828 | $439.91 | $364k | Jun 1, 2026 |
| BOZIC CARMENOfficer | Sell | 2.0k | $450.00 | $888k | May 29, 2026 |
| BUNNAGE MARK E.Officer | Sell | 33 | $453.45 | $15k | May 15, 2026 |
| BOZIC CARMENOfficer | Sell | 1.4k | $453.45 | $614k | May 15, 2026 |
| BOZIC CARMENOfficer | Sell | 7.0k | $450.00 | $3.14M | May 12, 2026 |
No analyst notes on VRTX yet.
Analyst Ratings
28 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 6 | 20 | 4 | 1 | 1 | Buy2.09 |
| 1 mo ago | 6 | 20 | 4 | 1 | 1 | Buy2.09 |
| 2 mo ago | 4 | 19 | 4 | 1 | 1 | Buy2.17 |
| 3 mo ago | 4 | 19 | 4 | 1 | 1 | Buy2.17 |
Members whose judged calls on VRTX have played out most reliably.
No settled calls on VRTX yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice